SUSQUEHANNA INTERNATIONAL GROUP, LLP - PROTARA THERAPEUTICS INC ownership

PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 32 filers reported holding PROTARA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PROTARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$58,402
+24.3%
34,971
+119.0%
0.00%
Q2 2022$47,000
-32.9%
15,969
+16.2%
0.00%
Q1 2022$70,000
-81.4%
13,739
-75.3%
0.00%
Q4 2021$376,000
+64.9%
55,724
+68.9%
0.00%
Q3 2021$228,000
+13.4%
32,993
+60.1%
0.00%
Q2 2021$201,00020,6090.00%
Other shareholders
PROTARA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,692,594$4,496,6321.46%
Privium Fund Management (UK) Ltd 119,730$201,1460.16%
Ikarian Capital, LLC 188,664$315,0690.04%
Orbimed Advisors 772,584$1,290,2150.03%
Boxer Capital, LLC 209,227$349,4090.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 64,000$106,8800.00%
Baker Brothers Advisors 199,671$333,4510.00%
BOOTHBAY FUND MANAGEMENT, LLC 18,864$31,5030.00%
TWO SIGMA INVESTMENTS, LP 27,345$45,6660.00%
OSAIC HOLDINGS, INC. 100$1670.00%
View complete list of PROTARA THERAPEUTICS INC shareholders